Page 15 - The Indian EYE 020626
P. 15

Op-Ed                                                              FEBRUARY 06, 2026       |  The Indian Eye 15



        and societies. Will human intelli-
        gence be diminished or augmented?
        How do individuals retain agency in
        systems increasingly governed by al-
        gorithms? Can intelligence remain
        plural, or will it converge into a few
        dominant  models  controlled  by  a
        handful of actors?
            These concerns have given rise
        to what many at Davos describe as
        a necessary “human intelligence
        shift”—a deliberate effort to design
        AI systems that enhance human dig-
        nity, judgment, and purpose rather
        than replace them. The challenge is
        no longer technical alone; it is moral
        and societal.
                 Governance in
               the Intelligent Age
            Nowhere is this challenge more
        evident than in debates around gov-
        ernance.  Artificial  intelligence  has
        become  a  defining  instrument  of
        21st-century  power,  shaping  eco-
        nomic competitiveness, military   Advances in robotics, multimodal reasoning, and embodied systems are collapsing the distance between thought and execution (MS File photo)
        capability, and information ecosys-
        tems. At Davos, leaders expressed   digital public infrastructure, a vast   institutions like the National Insti-  a Global AI Impact Summit in New
        growing  concern  about  cybersecu-  talent pool, democratic governance,  tute of Pharmaceutical Education   Delhi  reflects  a  determination  to
        rity  vulnerabilities,  regulatory  frag-  and growing industrial capacity.  and Research. At the same time, ed-  shape  inclusive  norms  and  ensure
        mentation, and the risk of techno-                                  ucational priorities are evolving to-  that  the  benefits  of  intelligence  at
        logical concentration.               AI and the Reinvention of      ward bioinformatics, computational   scale  are  not  confined  to  a  small
            An overwhelming majority of       India’s Pharmaceutical                                          group of nations.
        surveyed executives identified AI-re-       Ecosystem               biology, vaccinology, and AI-driven
        lated risks as among the most serious   Perhaps the most consequential   pharmacovigilance—skills essential   Conclusion: Intelligence With
                                                                            for high-value manufacturing and
        facing  the  global  system.  The  ques-  dimension of India’s Davos narra-  research.                         Responsibility
        tion is no longer whether AI should   tive  lies  in  its  pharmaceutical  and                            Davos  2026  confirms  that  ar-
        be regulated, but whose regulatory   life-sciences sector. Long known as   From States to the Global   tificial  intelligence  is  no  longer  a
        philosophy will prevail. Competing                                               Stage                sectoral phenomenon. It is a civili-
        models—from market-driven inno-   the “pharmacy of the world,” India    India’s federal innovation model   zational  force  that  will  define  how
                                          is now undergoing a strategic transi-
        vation to state-centric control—are   tion toward becoming a global inno-  was also on display at Davos. States   economies grow,  how power is dis-
        vying to define global norms.     vation partner.                   such as Madhya Pradesh showcased   tributed, and how societies function.
            The lingering impact of last                                    pharmaceutical manufacturing and      The Intelligent Age demands
                                              India already hosts the largest
        year’s  disruption  by  Chinese  firm   number of FDA-approved pharma-  supply-chain resilience, while Telan-  more  than  faster  machines.  It  re-
        DeepSeek, which claimed cost-ef-  ceutical manufacturing plants out-  gana highlighted AI-led disruption   quires  infrastructure  with  foresight,
        ficient  parity  with  OpenAI,  under-  side the United States and remains   in medical technology, positioning   governance with legitimacy, innova-
        scored  how  quickly  leadership  can   a dominant supplier of generics and   Hyderabad as a global knowledge   tion with inclusion, and intelligence
        shift—and how fragile dominance   vaccines. What is changing is the   and innovation hub. These sub-na-  guided by human values.
        can be.                           value profile. The industry is rapid-  tional efforts reinforce India’s   India’s  emergence  as  a  confi-
         India’s Emergence as a Shaper,   ly moving toward complex generics,   broader strategy of distributed, scal-  dent, values-driven AI leader adds a
                not a Spectator           biosimilars, and high-value active   able growth.                   crucial dimension to this global mo-
            Against this complex backdrop,  pharmaceutical ingredients, sup-  A Long-Term Vision for India    ment. The future will not be shaped
        India’s  presence  at  Davos  2026   ported increasingly by AI-driven        and the World            by who builds the largest models, but
                                                                                                              by who builds the most trusted, hu-
        stands out not for its scale alone, but   processes.                    India’s ambitions extend well
        for its confidence and coherence. In-  By 2026, roughly one-fifth of In-  beyond  the current  decade. The   man-centered systems.
                                                                                                                  The Intelligent Age has begun.
        dia is no longer content to be viewed   dian pharmaceutical companies are   country aims to grow its pharmaceu-  The responsibility to shape it wisely
        as a back-office or downstream con-  deploying AI across quality analytics,  tical sector to over US$120 billion by   is now collective.
        sumer of AI innovation. It is posi-  regulatory compliance, operation-  2030 and to as much as US$500 bil-
        tioning itself as a full-stack, first-tier   al  workflows,  and  drug  discovery.  lion by 2047 under its long-term na-
        AI power.                         These  tools  are  accelerating  devel-  tional  vision.  Artificial  intelligence   H S Panaser: Chairman, Global Indi-
            Union IT Minister Ashwini     opment timelines by as much as 25   is central to this trajectory, not as   an Trade and Cultural Council, USA
        Vaishnaw used the Davos platform   to  50  percent,  fundamentally  alter-  an end in itself, but as a multiplier   l  Business  Development  Consultant
        to firmly reject the notion of a US–  ing the economics of innovation.  of  productivity,  quality,  and  global   in Pharmaceuticals, IT and AI I EDP
        China duopoly, asserting that India   Government initiatives such as   competitiveness.               I Advisor in merger and acquisitions I
        belongs to the leading group of glob-  the Promotion of Research and In-  Equally  significant  is  India’s   GSK I Ex Chair, USINPAC I President
        al AI nations.  India’s  strength  lies   novation in the Pharma MedTech   positioning as a bridge between   at Global Indian Diaspora Alliance l
        not in a single breakthrough, but in   Sector are reinforcing this shift, with   advanced AI economies and the   Associated with Prof. Harkishan Singh
        its integrated approach—combining   Centres of Excellence established at   Global South. Its announcement of   Foundation I Social Activist I Columnist


                                                               www.TheIndianEYE.com
   10   11   12   13   14   15   16   17   18   19   20